AB&B BIO-TECH-B(02627.HK)

Company Encyclopedia

AB&B BIO-TECH-B

02627.HK

Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases. The company offers various vaccines, such as human rabies vaccine, pneumococcal vaccine, zoster vaccine, respiratory syncytial virus vaccine, mpox vaccine, varicella vaccine, and tetanus vaccine. The company was founded in 2015 and is based in Taizhou, China.

1.350 T

02627.HKMarket value -Rank by Market Cap -/-

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Youcai An	28.66%	No Change	08/08/2025
Ab&B Bio-Tech CO., LTD. JS, ESOP	8.89%	No Change	08/08/2025
Jiangsu Jiequan Gaotejia Medical Industry Investment Fund (Limited Partnership)	7.55%	No Change	08/08/2025
Shanghai Yijiucheng Investment Co., Ltd	6.8%	No Change	08/08/2025
Yiming He	4.13%	No Change	08/08/2025
Yingke Innovation Asset Management Co., Ltd.	3.92%	No Change	08/08/2025
HLC Healthmedical HK Limited	3.06%	No Change	08/08/2025
Beijing CGP Investment Co, Ltd.	2.52%	No Change	08/08/2025
Zhuzhou National Innovation Medicine Investment Partnership (Limited Partnership)	2.45%	No Change	08/08/2025
Pingtan Wenzhou Hangshi Ruihui Investment Partnership (Limited Partnership)	2.18%	No Change	08/08/2025